Illustrative image – not actual.Akums Drugs and Pharmaceuticals has announced plans to acquire the manufacturing business of Oriflame India for Rs 56 crore, marking the company’s entry into the colour cosmetics segment.
The acquisition will be carried out through Akums’ wholly owned subsidiary, Pure and Cure Healthcare, following approval from the company’s board. The transaction includes two manufacturing facilities located in Roorkee, Uttarakhand, and Noida, Uttar Pradesh, along with a leased warehouse in Noida. The deal will be completed through a cash consideration structure and is expected to close by August 31, 2026, subject to customary regulatory and closing conditions. Akums said the acquisition supports its strategy of expanding beyond pharmaceuticals into high-growth consumer categories. The acquired facilities offer manufacturing capabilities across skincare, wellness, hair care, and colour cosmetics, enabling the company to cater to both domestic and international brands.
Akums Managing Director Sanjeev Jain highlighted the growing opportunity in India’s cosmetics segment and said the acquired facilities would provide immediate manufacturing capacity and expertise. The move strengthens Akums’ diversification strategy while allowing it to participate in the expanding beauty and personal care industry.
